← back to search

Natalia Neparidze

Yale Cancer Center · US
🔎 Find collaborators in Hematology · Oncology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Hematology · Oncology
Research interest
Research interests include Medicine, Multiple myeloma, Monoclonal gammopathy of undetermined significance, Internal medicine, Coronavirus disease 2019 (COVID-19), and Stem cell.
h-index
citations
1,656
works
11
NIH funding
primary concept
email

Recent publications

Associations Between Patient Characteristics and Progression to Multiple Myeloma Among Patients With Monoclonal Gammopathy of Undetermined Significance: A Systematic Review
Clinical Lymphoma Myeloma & Leukemia 2024cited by 4position: middledoi
Cost-Effectiveness of First-Line Versus Second-Line Use of Daratumumab in Older, Transplant-Ineligible Patients With Multiple Myeloma
Journal of Clinical Oncology 2021cited by 39position: middledoi
Impact of the COVID-19 Pandemic on Treatment Patterns for Patients With Metastatic Solid Cancer in the United States
JNCI Journal of the National Cancer Institute 2021cited by 14position: middledoi
Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study
The Lancet Haematology 2020cited by 1,148position: middledoi
Differential effects of PD-L1 versus PD-1 blockade on myeloid inflammation in human cancer
JCI Insight 2020cited by 62position: middledoi
Chromosome 1 abnormalities and survival of patients with multiple myeloma in the era of novel agents
Blood Advances 2020cited by 52position: lastdoi
Early alterations in stem-like/marrow-resident T cells and innate and myeloid cells in preneoplastic gammopathy
JCI Insight 2019cited by 166position: middledoi
A highly efficient and faithful MDS patient-derived xenotransplantation model for pre-clinical studies
Nature Communications 2019cited by 80position: middledoi
Atezolizumab in Combination with Daratumumab with or without Lenalidomide or Pomalidomide: A Phase Ib Study in Patients with Multiple Myeloma
Blood 2018cited by 21position: middledoi
Impact of HIV on Clinical Presentation and Outcomes of Individuals with Multiple Myeloma
Blood 2018cited by 0position: lastdoi
Whole-exome sequencing in evaluation of patients with venous thromboembolism
Blood Advances 2017cited by 70position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Noffar Bar · Yale Cancer Center4 papers (2019–2021)Terri L. Parker · Yale Cancer Center3 papers (2019–2021)Smith Giri · O'Neal Comprehensive Cancer Center3 papers (2018–2021)Samuel S. McCachren · Emory University2 papers (2019–2020)Katherine E. Pendleton · Baylor College of Medicine2 papers (2019–2020)Mina L. Xu · Yale University2 papers (2019–2020)Kavita M. Dhodapkar · Fred Hutch Cancer Center2 papers (2019–2020)Jonathan L. Kaufman · Lipella Pharmaceuticals (United States)2 papers (2018–2019)Madhav V. Dhodapkar · Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa2 papers (2019–2020)Hearn Jay Cho · Mount Sinai Hospital2 papers (2018–2020)Ellice Wong · Yale Cancer Center2 papers (2018–2019)Nikolai A. Podoltsev · Yale Cancer Center2 papers (2019–2020)Amy J. Davidoff · Yale University2 papers (2020–2021)Ajay K. Nooka · Emory University2 papers (2019–2020)Scott F. Huntington · Yale Cancer Center2 papers (2020–2021)Jithendra Kini Bailur · Emory University2 papers (2019–2020)Stephanie Halene · Yale New Haven Hospital2 papers (2019–2020)Ronac Mamtani · Flatiron Health (United States)1 papers (2021–2021)Rong Wang · Yale Cancer Center1 papers (2024–2024)Gaurav Goyal · Birmingham VA Medical Center1 papers (2021–2021)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Hematology · Oncology →